Nicole S Arellano

6PUBLICATIONS
43CO-AUTHORS
Liquid biopsiesPredictive and prognostic markersMolecular targetsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 22, 2025
Type 2 calreticulin mutations activate ATF6 to promote BCL-xL-mediated survival in myeloproliferative neoplasms.

Nicole S Arellano, William L Heaton, Mirielle C Nauman

|Nov 06, 2024
Predicting drug resistance.

Nicole S Arellano, Shannon E Elf

|Jan 31, 2024
NRAS Mutant Dictates AHCYL1-Governed ER Calcium Homeostasis for Melanoma Tumor Growth.

Chufan Cai, Jiayi Tu, Jeronimo Najarro

Pageof 1